The estimated Net Worth of Shai Gozani is at least $13.6 Million dollars as of 2 May 2024. Shai Gozani owns over 636 units of Neurometrix stock worth over $43,298 and over the last 19 years he sold NURO stock worth over $12,734,674. In addition, he makes $775,030 as Chairman of the Board, President, Chief Executive Officer, Secretary, and Director at Neurometrix.
Shai has made over 105 trades of the Neurometrix stock since 2005, according to the Form 4 filled with the SEC. Most recently he exercised 636 units of NURO stock worth $2,843 on 2 May 2024.
The largest trade he's ever made was buying 100,000 units of Neurometrix stock on 27 February 2009 worth over $130,000. On average, Shai trades about 6,527 units every 42 days since 2005. As of 2 May 2024 he still owns at least 11,608 units of Neurometrix stock.
You can see the complete history of Shai Gozani stock trades at the bottom of the page.
Dr. Shai N. Gozani M.D. Ph.D. serves as Chairman of the Board, President, Chief Executive Officer, Secretary, Director of the Company.D. serves as Chairman of the Board, President, Chief Executive Officer, Secretary, Director of the Company. Dr. Gozani has served in a number of positions at our company including Chairman since 1996, President from 1996 to 1998 and from 2002 to the present, Chief Executive Officer since 1997 and Secretary since July 2008. Dr. Gozani holds a B.A. in computer science, an M.S. in Biomedical Engineering and a Ph.D. in Neurobiology, from the University of California, Berkeley. He also received an M.D. from Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences at M.I.T. Prior to forming our company, Dr. Gozani completed a neurophysiology research fellowship in the laboratory of Dr. Gerald Fischbach at Harvard Medical School. Dr. Gozani has published articles in the areas of basic and clinical neurophysiology, biomedical engineering and computational chemistry. The Board has concluded that Dr. Gozani should serve as a director because Dr. Gozani’s extensive knowledge of engineering and neurophysiology, combined with the unique understanding of our technology and business he has gained as our founder and as a key executive, provides invaluable insight to our Board and to the entire organization.
As the Chairman of the Board, President, Chief Executive Officer, Secretary, and Director of Neurometrix, the total compensation of Shai Gozani at Neurometrix is $775,030. There are no executives at Neurometrix getting paid more.
Shai Gozani is 55, he's been the Chairman of the Board, President, Chief Executive Officer, Secretary, and Director of Neurometrix since 2008. There are 7 older and no younger executives at Neurometrix. The oldest executive at Neurometrix Inc. is Thomas T. Higgins, 69, who is the Sr. VP, CFO & Treasurer.
Shai's mailing address filed with the SEC is C/O NEUROMETRIX, INC., 4B GILL STREET, WOBURN, MA, 01801.
Over the last 20 years, insiders at Neurometrix have traded over $14,886,276 worth of Neurometrix stock and bought 3,074,896 units worth $6,396,868 . The most active insiders traders include James Edeerfield Capital Lp..., Capital Partners, Lp Topline, and Capital Management, Llc Mc .... On average, Neurometrix executives and independent directors trade stock every 45 days with the average trade being worth of $133,905. The most recent stock trade was executed by Thomas T Higgins on 2 May 2024, trading 498 units of NURO stock currently worth $2,226.
neurometrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. the company maintains an active research effort and has several pipeline programs. the company is located in waltham, massachusetts and was founded as a spinoff from the harvard-mit division of health sciences and technology in 1996. for more information, please visit neurometrix.com. neurometrix markets the following products: quell® wearable pain relief technology™ quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. it combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. quell launc
Neurometrix executives and other stock owners filed with the SEC include: